Results from a Randomized Clinical Trial of Coadministration of RotaTeq, a Pentavalent Rotavirus Vaccine, and NeisVac-C, a Meningococcal Serogroup C Conjugate Vaccine

RotaTeq (Merck & Co. Inc./Sanofi Pasteur MSD) is a three-dose, oral pentavalent rotavirus vaccine for the immunization of infants from 6 weeks of age for the prevention of rotavirus gastroenteritis. The primary objective of the present trial was to demonstrate that RotaTeq can be coadministered...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Vesikari, Timo, Karvonen, Aino, Borrow, Ray, Kitchin, Nick, Baudin, Martine, Thomas, Stéphane, Fiquet, Anne
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2011
Assuntos:
Vaccine Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3122533/
https://ncbi.nlm.nih.gov/pubmed/21389149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00437-10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados